Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy

H. Schlögl, A. Villringer, K. Miehle, M. Fasshauer, M. Stumvoll, K. Mueller

. 2023 ; 7 (8) : bvad072. [pub] 20230606

Status not-indexed Language English Country United States

Document type Journal Article

CONTEXT: Research in lipodystrophy (LD) and its treatment with metreleptin has not only helped patients with LD but has opened new directions in investigating leptin's role in metabolism and the regulation of eating behavior. Previously, in a study with patients with LD undergoing metreleptin treatment using functional magnetic resonance imaging (MRI), we found significantly increased resting-state brain connectivity in 3 brain areas including the hypothalamus. OBJECTIVE: In this study, we aimed to reproduce our functional MRI findings in an independent sample and compare results to healthy participants. DESIGN: Measurements in 4 female patients with LD undergoing metreleptin treatment and 3 healthy untreated controls were performed at 4 different time points over 12 weeks. To identify treatment-related brain connectivity alterations, eigenvector centrality was computed from resting-state functional MRI data for each patient and each session. Thereafter, analysis aimed at detecting consistent brain connectivity changes over time across all patients. RESULTS: In parallel to metreleptin treatment of the patients with LD, we found a significant brain connectivity increase in the hypothalamus and bilaterally in posterior cingulate gyrus. Using a 3-factorial model, a significant interaction between group and time was found in the hypothalamus. CONCLUSIONS: Investigating brain connectivity alterations with metreleptin treatment using an independent sample of patients with LD, we have reproduced an increase of brain connectivity in hedonic and homeostatic central nervous networks observed previously with metreleptin treatment. These results are an important contribution to ascertain brain leptin action and help build a foundation for further research of central nervous effects of this important metabolic hormone.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015795
003      
CZ-PrNML
005      
20231020093643.0
007      
ta
008      
231010s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1210/jendso/bvad072 $2 doi
035    __
$a (PubMed)37404242
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Schlögl, Haiko $u Department of Endocrinology, Nephrology, Rheumatology, Division of Endocrinology, University Hospital Leipzig, 04103 Leipzig, Germany $u Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, 04103 Leipzig, Germany $1 https://orcid.org/0000000239675318
245    10
$a Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy / $c H. Schlögl, A. Villringer, K. Miehle, M. Fasshauer, M. Stumvoll, K. Mueller
520    9_
$a CONTEXT: Research in lipodystrophy (LD) and its treatment with metreleptin has not only helped patients with LD but has opened new directions in investigating leptin's role in metabolism and the regulation of eating behavior. Previously, in a study with patients with LD undergoing metreleptin treatment using functional magnetic resonance imaging (MRI), we found significantly increased resting-state brain connectivity in 3 brain areas including the hypothalamus. OBJECTIVE: In this study, we aimed to reproduce our functional MRI findings in an independent sample and compare results to healthy participants. DESIGN: Measurements in 4 female patients with LD undergoing metreleptin treatment and 3 healthy untreated controls were performed at 4 different time points over 12 weeks. To identify treatment-related brain connectivity alterations, eigenvector centrality was computed from resting-state functional MRI data for each patient and each session. Thereafter, analysis aimed at detecting consistent brain connectivity changes over time across all patients. RESULTS: In parallel to metreleptin treatment of the patients with LD, we found a significant brain connectivity increase in the hypothalamus and bilaterally in posterior cingulate gyrus. Using a 3-factorial model, a significant interaction between group and time was found in the hypothalamus. CONCLUSIONS: Investigating brain connectivity alterations with metreleptin treatment using an independent sample of patients with LD, we have reproduced an increase of brain connectivity in hedonic and homeostatic central nervous networks observed previously with metreleptin treatment. These results are an important contribution to ascertain brain leptin action and help build a foundation for further research of central nervous effects of this important metabolic hormone.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Villringer, Arno $u Max-Planck-Institute for Human Cognitive and Brain Sciences, 04103 Leipzig, Germany $u Day Clinic of Cognitive Neurology, University of Leipzig, 04103 Leipzig, Germany $1 https://orcid.org/0000000326042404
700    1_
$a Miehle, Konstanze $u Department of Endocrinology, Nephrology, Rheumatology, Division of Endocrinology, University Hospital Leipzig, 04103 Leipzig, Germany
700    1_
$a Fasshauer, Mathias $u Institute of Nutritional Sciences, Justus-Liebig-University, 35392 Giessen, Germany
700    1_
$a Stumvoll, Michael $u Department of Endocrinology, Nephrology, Rheumatology, Division of Endocrinology, University Hospital Leipzig, 04103 Leipzig, Germany $u Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, 04103 Leipzig, Germany $1 https://orcid.org/0000000162258240
700    1_
$a Mueller, Karsten $u Max-Planck-Institute for Human Cognitive and Brain Sciences, 04103 Leipzig, Germany $u Department of Neurology, Charles University, First Faculty of Medicine and General University Hospital, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000196130552
773    0_
$w MED00209724 $t Journal of the Endocrine Society $x 2472-1972 $g Roč. 7, č. 8 (2023), s. bvad072
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37404242 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20231020093637 $b ABA008
999    __
$a ok $b bmc $g 1997269 $s 1202157
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 7 $c 8 $d bvad072 $e 20230606 $i 2472-1972 $m Journal of the Endocrine Society $n J Endocr Soc $x MED00209724
LZP    __
$a Pubmed-20231010

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...